XJPX
4914
Market cap782mUSD
Oct 09, Last price
1,285.00JPY
1D
1.42%
1Q
10.68%
Jan 2017
-58.41%
Name
Takasago International Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Takasago International Corporation focuses on the development and sale of flavorings, fragrances, aroma ingredients, and various specialized fine chemicals. Its wide selection of flavor compounds is integrated into a diverse range of food and drink items. This includes numerous beverage types such as fruit juices, carbonated sodas, coffee and tea-based drinks, sports and energy beverages, dairy products, alcoholic and non-alcoholic options, as well as powdered mixes and protein meal replacements. The company's flavors are also vital components in confectionery items like candies, chewing gums, chocolates, and cereal bars; processed foods such as meats, seasoning blends, soups, and seafood; baked goods including breads, pastries, cookies, and cakes; and dairy offerings like yogurts, flavored milks, ice creams, and frozen desserts. Additionally, Takasago's expertise extends to oral care products like toothpastes, mouthwashes, and breath fresheners. The corporation's fragrances are incorporated into fine perfumes and colognes, alongside a broad spectrum of consumer goods such as soaps, shampoos, bath products, cosmetics, laundry detergents, household cleaners, and air fresheners. They also provide key aroma ingredients, which serve as foundational building blocks for creating these scented products. Furthermore, Takasago manufactures specialized fine chemicals that act as essential intermediates for the pharmaceutical and electronics industries. Founded in Tokyo, Japan, in 1920, the company operates globally across Japan, the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.
Key people
Satoshi Masumura
President, Executive President, Chief Executive Officer, Chief Senior Director of Safety, Representative Director · since 2016
Naoki Mizuno
Managing Executive Officer, Chief Director of Supply Chain Management, Chairman of Subsidiary, Director · since 2025
Andy Arguelles
Executive Officer, President of Subsidiaries · since 2025
Makoto Emura
Executive Officer, Deputy Director of Research and Development, Director of Research Institute for Biodesign · since 2024
Hiroyasu Hirata
Executive Officer, Chief Director of Administration, Director of Related Business, Manager of China Office, Manager of IR/PR Office · since 2024
Paul Ireland
Executive Officer, Director of Global Fragrance Business · since 2025
Akihiko Kawano
Executive Officer, Chief Deputy Director of Flavour · since 2023
Takayuki Kibayashi
Executive Officer, President of Subsidiary · since 2024
Toshiyuki Murayama
Executive Officer, Deputy Chief Director of Research and Development, Director of Analysis Research Institute · since 2025
Fuminori Sato
Executive Officer, Chief Director of Fragrance Aroma Ingredients Business, Director of Global Fragrance Business Strategy · since 2025
Kenji Yagi
Executive Officer, Chief Director of Procurement · since 2024
Shigeki Kawabata
Managing Executive Officer, Chief Director of Business Strategy, Director of Business Planning, Director of Legal Affairs, Director · since 2024
Kenichi Somekawa
Managing Executive Officer, Chief Director of Flavor Business, Chairman of Subsidiary, Director · since 2024
Tatsuya Yamagata
Managing Executive Officer, Chief Director of Corporate, Senior Director of International Quality Assurance, Deputy Chief Senior Director of Safety, Director of Global SAP Management, Director · since 2023
Fumihiro Yanaka
Managing Executive Officer, Chief Director of Research Development, Chief Director of Fine Chemicals Business, Director · since 2025
Komei Matsuda
Independent Director · since 2017
Independent Director · since 2001
Atsuko Tsuji
Independent Director · since 2024
Megumi Tsukamoto
Independent Director · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||